Skip to content

Robotic Rehabilitation of Upper Limb in PD

Upper Limb Rehabilitation Using Armeo Spring in Patients With Parkinson's Disease.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03893786
Enrollment
30
Registered
2019-03-28
Start date
2019-07-01
Completion date
2020-04-01
Last updated
2019-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

It has been shown that robot-assisted therapy may be considered an effective and reliable method for the delivery of highly repetitive training useful to boost neuroplasticity. Thus, an early, intensive, repetitive and task oriented training could be an ideal strategy to facilitate relearning of motor function and to improve motor function. The ARMEO-S® is a specific upper limb electromedical device mainly used to reduce spasticity and improve muscle force. To date robotic upper limb training has been applied only in patiebts with brain injury and spinal cord lesions. Aim of the study is to evaluate the efficacy of ARMEO-S in improving upper limb agility in a sample of PD patients, as compared to traditional physiotherapy.

Interventions

DEVICERobotic Rehabilitation

Fifteen patients with Parkinson's Disease will perform ten 45-minute training sessions of the upper limb bilaterally with the Armeo®Spring, an electromedicad device aimed at improving force and coordination in neurologically affected patients. The device was built to sustain the forearm during the upperlimb training and is equipped with a VR screen with which the patient may interact during the playful and motivating rehab.

Sponsors

IRCCS Centro Neurolesi Bonino Pulejo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Idiopathic PD diagnosed according to the UK BRAIN BANK criteria * Hoehn-Yahr stage 2- 3 * MMSE score ≥ 23

Exclusion criteria

* Severe Dyskinesia * On-Off Motor fluctuations * History of stereotaxic brain surgery for PD; * Changes in dopamine therapy dose in any time within 3 months prior to baseline; * Any other medical that may compromise the patient's participation in this study such as history of ostheoarthritis or neuropathies.

Design outcomes

Primary

MeasureTime frameDescription
UPDRS rating scale- Section III2 monthsTo assess whether PD patients may got better results in the motor part of the UPDRS after the UL training
Nine hole peg test2 monthsTo evaluate if the patients will get better dexterity after the robotic training

Secondary

MeasureTime frameDescription
Upper Limb Fugl-Mayer2 monthsto verify whether PD patients may present with an increase in muscle strenght after the treatment.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026